Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin.
Healy D, Bahrick A, Bak M, Barbato A, Calabrò RS, Chubak BM, Cosci F, Csoka AB, D'Avanzo B, Diviccaro S, Giatti S, Goldstein I, Graf H, Hellstrom WJG, Irwig MS, Jannini EA, Janssen PKC, Khera M, Kumar MT, Le Noury J, Lew-Starowicz M, Linden DEJ, Lüning C, Mangin D, Melcangi RC, Rodríguez OWMAAS, Panicker JN, Patacchini A, Pearlman AM, Pukall CF, Raj S, Reisman Y, Rubin RS, Schreiber R, Shipko S, Vašečková B, Waraich A.
Healy D, et al. Among authors: melcangi rc.
Int J Risk Saf Med. 2022;33(1):65-76. doi: 10.3233/JRS-210023.
Int J Risk Saf Med. 2022.
PMID: 34719438
Free PMC article.